MannKind develops dry powder inhaler for pulmonary hypertension treatment
Go back to MannKind develops dry powder inhaler for pulmonary hypertension treatment| Mannkind Corporation (NASDAQ: MNKD) | Delayed: 3.89 -0.05 (1.27%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.94 | 52 Week High | $2.51 | |||
| Open | $3.95 | 52 Week Low | $0.41 | |||
| Day High | $4.06 | P/E | N/A | |||
| Day Low | $3.88 | EPS | $-0.64 | |||
| Volume | 3,562,816 | |||||
| United Therapeutics Corp (NASDAQ: UTHR) | Delayed: 538.30 +1.71 (0.32%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $536.59 | 52 Week High | $164.04 | |||
| Open | $541.25 | 52 Week Low | $97.52 | |||
| Day High | $541.53 | P/E | 98.41 | |||
| Day Low | $533.49 | EPS | $5.47 | |||
| Volume | 620,875 | |||||
